Education
About Us
Working with TipRanks
Follow Us
AdaptHealth (AHCO)
NASDAQ:AHCO
AHCO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.11 - $11.70
Previous CloseN/A
Volume245.49K
Average Volume (3M)1.36M
Market Cap
$1.24B
Enterprise Value$3.18B
Total Cash (Recent Filing)$68.63M
Total Debt (Recent Filing)$157.39M
Price to Earnings (P/E)17.2
Beta0.95
Next Earnings
Nov 11, 2025EPS Estimate
0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.22
Shares Outstanding135,297,760
10 Day Avg. Volume1,394,702
30 Day Avg. Volume1,356,718
Financial Highlights & Ratios
PEG Ratio-0.13
Price to Book (P/B)0.81
Price to Sales (P/S)0.39
P/FCF Ratio5.40
Enterprise Value/Market Cap2.56
Enterprise Value/Revenue0.98
Enterprise Value/Gross Profit7.27
Enterprise Value/Ebitda6.81
Forecast
1Y Price Target
$12.50Price Target Upside36.02% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
Cash Flow PerformanceEncouragingly, free cash flow guidance was only reduced by $20 million at the midpoint of the range, implying a better-than-expected cash flow performance in the first half of the year.
Diabetes ProgressDiabetes continues to show signs of early progress, exceeding internal targets for the quarter.
Strategic DivestituresAdapthealth closed its previously announced sale of incontinence/infusion assets, furthering its strategic non-core asset divestitures.
Bears Say
EBITDA Margin DeclineEBITDA margin declined 110 basis points year-over-year to 19.4%.
Revenue OutlookAdapthealth lowered its 2025 revenue outlook by about 1% at the midpoint.
Sleep Segment ChallengesNew challenges in sleep entered the picture this quarter, with competitors gaining share in a few states.
AdaptHealth News
AHCO FAQ
What was AdaptHealth’s price range in the past 12 months?
AdaptHealth lowest stock price was $7.11 and its highest was $11.70 in the past 12 months.
What is AdaptHealth’s market cap?
AdaptHealth’s market cap is $1.24B.
When is AdaptHealth’s upcoming earnings report date?
AdaptHealth’s upcoming earnings report date is Nov 11, 2025 which is in 91 days.
How were AdaptHealth’s earnings last quarter?
AdaptHealth released its earnings results on Aug 05, 2025. The company reported $0.218 earnings per share for the quarter, beating the consensus estimate of $0.158 by $0.06.
Is AdaptHealth overvalued?
According to Wall Street analysts AdaptHealth’s price is currently Undervalued.
Does AdaptHealth pay dividends?
AdaptHealth does not currently pay dividends.
What is AdaptHealth’s EPS estimate?
AdaptHealth’s EPS estimate is 0.26.
How many shares outstanding does AdaptHealth have?
AdaptHealth has 135,297,760 shares outstanding.
What happened to AdaptHealth’s price movement after its last earnings report?
AdaptHealth reported an EPS of $0.218 in its last earnings report, beating expectations of $0.158. Following the earnings report the stock price went up 10.977%.
Which hedge fund is a major shareholder of AdaptHealth?
Currently, no hedge funds are holding shares in AHCO
AdaptHealth Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.50 (36.02% Upside)
$12.50 (36.02% Upside)
Blogger Sentiment
Bullish
AHCO Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 5.8%
Last 30 Days ▲ 16.0%
Last 30 Days ▲ 16.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.05%
12-Months-Change
Fundamentals
Return on Equity
4.76%
Trailing 12-Months
Asset Growth
-3.55%
Trailing 12-Months
Company Description
AdaptHealth
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
AHCO Company Deck
AHCO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixture of positive developments and challenges. The announcement of a major new contract and improvements in key segments are significant positives. However, these are offset by revenue declines, reduced EBITDA guidance, and potential future challenges from CMS rule changes.View all AHCO earnings summariesAHCO Stock 12 Month Forecast
Average Price Target
$12.50
▲(36.02% Upside)
Technical Analysis
Ufp Technologies
―
LivaNova
―
Senseonics Holdings
―
Establishment Labs Holdings
―
Bioventus
―
Ownership Overview
3.30% Insiders
22.68% Mutual Funds
6.14% Other Institutional Investors
44.47% Public Companies and
Individual Investors